首页> 外国专利> Use of gaboxadol and its derivatives as kinase inhibitor for the treatment of e.g. kinase induced disease, cancer, age-related macular degeneration, diabetic retinopathy and angiogenesis

Use of gaboxadol and its derivatives as kinase inhibitor for the treatment of e.g. kinase induced disease, cancer, age-related macular degeneration, diabetic retinopathy and angiogenesis

机译:加波沙朵及其衍生物作为激酶抑制剂用于治疗例如激酶诱导的疾病,癌症,与年龄有关的黄斑变性,糖尿病性视网膜病变和血管生成

摘要

Use of gaboxadol and its derivatives (A) as a kinase inhibitor for the treatment of kinase induced diseases. ACTIVITY : Cytostatic; Ophthalmological; Antiangiogenic; Antiarthritic; Antiarteriosclerotic; Antipsoriatic; Dermatological; Endocrine-Gen.; Neuroprotective; Nootropic; Antiparkinsonian; CNS-Gen.; Muscular-Gen.; Vasotropic; Cerebroprotective; Anticonvulsant; Anti-HIV; Tranquilizer. MECHANISM OF ACTION : Kinase inhibitor; Rho-kinase inhibitor. The kinase inhibiting activity of (I) to treat kinase-induced disease was tested using biological assays. The results showed that (I) inhibits the kinase induced disease at 10 mu M.
机译:加波沙朵及其衍生物(A)作为激酶抑制剂用于治疗激酶诱导的疾病的用途。活动:细胞抑制;眼科抗血管生成;抗关节炎抗动脉硬化;对牛皮癣;皮肤;内分泌根具有神经保护作用;促智;反帕金森病; CNS-Gen .;肌肉型;变压性脑保护抗惊厥药;抗艾滋病毒;镇静剂。作用机理:激酶抑制剂; Rho激酶抑制剂。使用生物学测定法测试了(I)治疗激酶诱导的疾病的激酶抑制活性。结果表明(I)在10μM下抑制了激酶诱导的疾病。

著录项

  • 公开/公告号DE102005020882A1

    专利类型

  • 公开/公告日2006-11-09

    原文格式PDF

  • 申请/专利权人 DOEMLING ALEXANDER;

    申请/专利号DE20051020882

  • 发明设计人

    申请日2005-05-04

  • 分类号A61K31/423;A61P35;

  • 国家 DE

  • 入库时间 2022-08-21 21:20:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号